Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Psoriasis”

Showing 20 of 0 results

Not applicableLooking for participantsNCT07532486
What this trial is testing

Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis

Who this might be right for
Psoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine 400
Testing effectiveness (Phase 2)Looking for participantsNCT07129382
What this trial is testing

Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Chipscreen Biosciences, Ltd. 220
Large-scale testing (Phase 3)Study completedNCT04167462
What this trial is testing

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea

Who this might be right for
Psoriasis
Bristol-Myers Squibb 220
Not applicableLooking for participantsNCT07234591
What this trial is testing

Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisModerate to Severe Plaque Psoriasis
Usynova Pharmaceuticals Ltd. 140
Large-scale testing (Phase 3)Study completedNCT05020249
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
UCB Biopharma SRL 47
Post-approval studies (Phase 4)Study completedNCT01187264
What this trial is testing

Dose Ranging Study to Compare the Efficacy and Safety of Methotrexate in Plaque Type Psoriasis

Who this might be right for
Psoriasis
Post Graduate Institute of Medical Education and Research, Chandigarh 100
Testing effectiveness (Phase 2)Study completedNCT01748539
What this trial is testing

Clinical Study of KHK4827

Who this might be right for
Moderate to Severe Plaque Psoriasis
Kyowa Kirin Co., Ltd. 140
Early research (Phase 1)Study completedNCT01836939
What this trial is testing

Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Mark Lebwohl 8
Testing effectiveness (Phase 2)Study completedNCT02223039
What this trial is testing

Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbGenomics B.V Taiwan Branch 50
Testing effectiveness (Phase 2)Ended earlyNCT05044234
What this trial is testing

Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
AbbVie 156
Large-scale testing (Phase 3)Active Not RecruitingNCT06220604
What this trial is testing

JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 731
Large-scale testing (Phase 3)Study completedNCT03504852
What this trial is testing

Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 331
Not applicableStudy completedNCT04203693
What this trial is testing

Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 331
Testing effectiveness (Phase 2)Study completedNCT00320216
What this trial is testing

A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 320
Testing effectiveness (Phase 2)Ended earlyNCT03835481
What this trial is testing

Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is

Who this might be right for
Psoriasis
Boehringer Ingelheim 165
Testing effectiveness (Phase 2)Study completedNCT07707141
What this trial is testing

Safety and Efficacy of HPP737 in Adult Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Newsoara Biopharma Co., Ltd. 123
Large-scale testing (Phase 3)Looking for participantsNCT04772079
What this trial is testing

Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bristol-Myers Squibb 153
Large-scale testing (Phase 3)Study completedNCT05073315
What this trial is testing

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 425
Testing effectiveness (Phase 2)Study completedNCT03421197
What this trial is testing

Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)

Who this might be right for
Psoriasis
Dr. Reddy's Laboratories Limited 426
Post-approval studies (Phase 4)Study completedNCT01039142
What this trial is testing

Dose Ranging Study to Assess the Efficacy and Safety of Acitretin in Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Post Graduate Institute of Medical Education and Research, Chandigarh 61
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation